| | 公司拟收购蓝微电子控制权，其业 | 感谢您的关注与提问！丰城纳尔与蓝微电子在市场渠道、客户资源、生 产工艺、产品研发等领域环节均无直接协同。双方位于江西省境内，仅 | | --- | --- | --- | | 15 | 务与丰城纳尔在土地、技术上有何 | 在土地资源、厂房建设和经营管理上有潜在互补，最终需要结合具体情 | | | 协同？ | 况进行研究，后续交易进展我们将会及时公告。 | | | 公司如何平衡传统材料（如数码喷 印）与新能源业务的资源分配？ | 您好，感谢您的提问，公司当前主营业务收入均来自数码喷印材料及汽 | | 16 | 2025 年是否计划通过定增、发债 | 车功能膜等行业，新能源领域聚焦氢能膜电极产品的研发，对资金资源 需求相对有限，公司暂无2025年度募资计划，一旦有需要，公司将严格 | | | 等方式募资，支持氢能源等新兴领 | 按程序决定、并及时公告。 | | | 域的研发与产能建设？ | | | | 2024 年拟 10 派 1.2 元，分红率 | 公司分红策略为依据公司发展所属阶段，考虑行业整体机会及公司经营 | | 17 | 约 30%。公司是否考虑在业绩增长 | ...

上海纳尔实业股份有限公司 投资者关系活动记录表 投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 参与单位名称及 人员姓名 线上参与公司纳尔股份 2024 年度网上业绩说明会的投资者 时间 2025 年 4 月 24 日（星期四） 15：00-17:00 地点 全景网"投资者关系互动平台"（https://ir.p5w.net） 约调研"纳尔股份 IR"微信小程序 上市公司接待人 员姓名 董事长、总经理：游爱国 副总经理、董事会秘书、财务总监：游爱军 投资者关系活动 主要内容介绍 游爱军主持本次业绩说明会，与会人员和公司相关人员采用问 答形式进行了沟通，具体内容详见问答列表。 接待过程中，公司与投资者进行了充分的交流与沟通，并严 格按照公司《信息披露管理制度》等规定，保证信息披露的真实、 准确、完整、及时、公平。没有出现未公开重大信息泄露等情况， 团体接待未签署《承诺书》 附件清单（如有） 业绩说明会问答列表 日期 2025 年 4 月 24 日 证券代码：002825 证券简称：纳尔股份 编号：2025-004 上海纳尔实业股份有限公司 ...

Group 1: Industry Overview - The company operates in the special electronic information industry, focusing on sonar equipment for underwater detection and communication [3] - Sonar equipment is a core technology for deep-sea exploration and is crucial for enhancing national marine capabilities [3] - The industry is supported by national policies and is classified as a strategic emerging industry [3][4] Group 2: Financial Performance - In 2024, the company's revenue reached 239.71 million yuan, a 45.65% increase from the adjusted revenue of 164.58 million yuan in the previous year [3] - The net profit attributable to shareholders was -26.14 million yuan, indicating a significant reduction in losses compared to the previous year [3] Group 3: Future Growth Prospects - The company plans to leverage its core technologies for industrial application, focusing on product performance optimization and expanding application scenarios [4] - The development of unmanned systems, artificial intelligence, and big data technologies presents opportunities for product functionality and performance enhancement [4] - Key R&D directions include intelligent marine information equipment, new signal processing devices, simulation training systems, and big data systems [4] Group 4: Market and Strategic Positioning - The company is currently focused on domestic operations, with no immediate impact from the US-China trade war [5] - There are plans to expand into civilian products, particularly in the marine equipment sector [6] - The growth of China's shipbuilding industry, with double-digit growth in key indicators, is expected to benefit the marine equipment sector and the company's business [6] Group 5: Challenges and Mitigation Strategies - Continuous losses are attributed to credit impairment losses and adjustments in variable pricing estimates [6] - The company aims to improve cash flow by enhancing accounts receivable collection and reducing bad debt risks [6] - Efforts will be made to accelerate payment cycles and improve operational efficiency [6]

Group 1: Financial Performance - The company's Q1 2025 revenue remained stable compared to the same period last year, while net profit saw significant growth due to optimized sales structure of polyurethane new materials, with a higher proportion of specialty products contributing to revenue [2] - The gross margin of specialty products is higher than that of general products, benefiting from structural optimization in the supply chain that reduced raw material procurement costs [2] - The Q2 performance is expected to be influenced by market demand, raw material prices, and company operations, with specific details to be disclosed in the semi-annual report [3] Group 2: Product Development and Applications - The PPDI product, known for its excellent physical and mechanical properties, is primarily used in high-end elastomer materials for military aerospace, high-end automotive shock absorbers, and oil drilling equipment seals [4] - The company is focusing on traditional industries such as coatings and automotive paints for HDI-related products, while also exploring new applications in polyurethane new materials [5] - The company has 8,000 tons of production capacity for foamed TPU, with plans to increase capacity by an additional 10,000 tons by the end of 2025 through ongoing projects [6] Group 3: Future Strategy - The company aims to leverage the synergy between upstream and downstream industries to promote the development of functional chemical raw materials and polyurethane new materials [7] - There is a plan to accelerate the industrialization of successfully developed specialty isocyanate-based polyurethane new materials and enhance market promotion efforts [8]

Group 1: Financial Performance - In 2024, the company achieved operating revenue of ¥2,763,726,947.39, a year-on-year increase of 35.69% [3] - Pet supplies revenue was ¥1,530,007,016.23, up 15.08%, while pet food revenue reached ¥1,175,863,791.58, a growth of 70.80% [3] - Net profit attributable to shareholders was ¥45,960,499.31, a decline of 40.13% [3] Group 2: Reasons for Profit Decline - Losses from newly established subsidiaries in the U.S. amounted to ¥13,361,600 [3] - Share-based payment expenses for the restricted stock incentive plan were approximately ¥11,089,300 [3] - Inventory impairment provisions totaled around ¥31,233,500 [3] - Increased marketing expenses due to partnerships with leading global pet food brands [3] Group 3: Market Position and Strategy - The company has established a competitive advantage through over 20 years of experience in the pet industry, focusing on supply chain management and multi-category product development [3] - U.S. market sales account for about one-third of the company's export revenue, indicating limited impact from U.S. tariffs [3][4] - The company is expanding its online retail capabilities through the acquisition of Guangzhou Taotong Technology Co., Ltd., which focuses on e-commerce [5] Group 4: Future Growth and Market Potential - The company aims to expand its domestic market presence while continuing to develop international markets [6] - In 2024, pet supplies sales were primarily international (55.36%), while pet food sales were mainly domestic (42.55%) [6] - The global pet goods market is projected to grow, with a retail scale of $193.53 billion in 2023, indicating significant market potential [7] Group 5: Operational Insights - The company has laid out plans to enhance online marketing efforts across various platforms, including Tmall and JD.com [9] - Raw material costs account for approximately 50% of production costs, with key materials including fabrics and plastics [8] - The company engages in ODM business with major international retailers, including Walmart and Kmart [7]

3.公司今年计划引入战略投资者吗？ 证券代码： 000617 证券简称：中油资本 中国石油集团资本股份有限公司投资者关系活动记录表 编号：2025-003 | 投资者关系活动 | □特定对象调研 □ 分析师会议 | | --- | --- | | 类别 | 媒体采访 业绩说明会 □ √ | | | 路演活动 □ 新闻发布会 □ | | | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位名称及 | | | | 投资者网上提问 | | 人员姓名 | | | 时间 | 2025 年 4 月 24 日 (周四) 下午 15:00~16:30 | | 地点 | 通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 和深圳证券交易所"互动易"平台"云访谈"栏目 | | | （http://irm.cninfo.com.cn)采用网络互动的方式进行 | | 上市公司接待人 | 1.副董事长、总经理何放 | | 员姓名 | 2.副总经理、财务总监、董事会秘书刘强 | | | 3.独立董事陈武朝 | | | 4.所属金融企业代表 | | | 5.财务部、证券事务 ...

Group 1: Business Strategy - The company is pursuing a dual development strategy in pharmaceuticals and new energy materials [1] - In the pharmaceutical sector, the focus is on leveraging advantages in the domestic pharmaceutical excipients industry, emphasizing "technology deepening, category expansion, and quality foundation" [1] - The new energy materials sector is enhancing resource development and innovating business models to secure the upstream supply chain [2] Group 2: Financial Performance - The first beneficiation plant of the company's Nigerian subsidiary was completed in Q4 2024, generating additional revenue of 77.27 million yuan in Q1 2025 [2] - The traditional Chinese medicine segment achieved revenue of 99.98 million yuan in 2024, marking a year-on-year growth of 461.40% [3] - R&D investment in 2024 amounted to 4.52 million yuan, representing 3.96% of total revenue [4] Group 3: Industry Trends - The pharmaceutical excipients industry faces increased pressure due to reforms in generic drug evaluations and procurement, leading to higher demands for production costs and product quality [2] - The National Medical Products Administration's announcement in January 2025 regarding the quality management norms for pharmaceutical excipients is expected to enhance market capacity and competitiveness for compliant manufacturers [2] Group 4: Future Plans - The company is establishing a pharmaceutical production base in Tanzania to meet local healthcare needs while utilizing local resources and advanced production technologies [4] - Plans to collaborate with AI technology companies to advance the industrialization of liver and gallbladder drugs are underway, with ongoing projects transitioning to pilot scale [4] - The company aims to explore capital operations through mergers and acquisitions to align with strategic goals in the pharmaceutical and new energy sectors [4]

证券代码：000931 证券简称：中关村 北京中关村科技发展（控股）股份有限公司 投资者关系活动记录表 编号：2025-001 | 投资者关系 | 特定对象调研  | 分析师会议 | 媒体采访 | | --- | --- | --- | --- | | 活动类别 | 业绩说明会 | 新闻发布会 | 路演活动 | | | 现场参观 | 其他 | | | 活动参与人员 | 华安证券 | 熊骥溟 | | | | 易方达基金 | 陈峻松 | | | | 天弘基金 吕 | 俏 | | | | 兴业基金 | 裘若桑 | | | | 万家基金 | 杨梦朝 | | | | 中信建投基金 | 吴县名 | | | | 红土创新基金 | 杨皓童 | | | | 金信基金 | 赵浩然 | | | 时间 | 2025 年 4 月 23 日至 4 月 | 24 日 | | | 地点 | 北京市朝阳区霄云路 26 | 号鹏润大厦 B 座 22 | 层公司会议室 | | 形式 | 网络平台线上交流 | | | | 上市公司接待 | 董事兼总裁：侯占军 | | | | 人员姓名 | 副总裁：车德辉、范秀君 | | | | | ...

江西阳光乳业股份有限公司投资者关系活动记录表 证券代码：001318 证券简称：阳光乳业 编号：2025-001 4、听闻公司大力发展高毛利的低温乳制品，请问公司的产品毛利 率现在有多少？ | 投资者关系活动类别 | □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 | □新闻发布会 | | --- | --- | --- | | | □路演活动 □现场参观 □其他（请文字说明其他活动内容） | | | 参与单位名称及 | 投资者网上提问 | | | 人员姓名 | | | | 时间 | 2025 年 4 月 24 日 (周四) 下午 15:00~17:00 | | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net）采用 | | | | 网络远程的方式召开业绩说明会 | | | | 1、董事长兼总经理胡霄云 | | | 上市公司接待人员 | 2、副总、董事会秘书杨发兴 | | | 姓名 | 3、独立董事陈荣 | | | | 4、财务负责人艾剑波 | | | | 投资者提出的问题及公司回复情况 | | | | 公司就投资者在本次说明会中提出的问题进行了回复： | | ...